ERLOTINIB 100 mg/1

Erlotinib 100 mg tablets are a targeted therapy used to treat certain types of cancer. This oral medication is designed to inhibit specific proteins that contribute to cancer cell growth.

Erlotinib is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Erlotinib is often prescribed as part of a comprehensive cancer treatment plan.

Common effects of Erlotinib may include skin rash, diarrhea, and fatigue. Some individuals may also experience appetite loss, nausea, or shortness of breath. These effects can vary in severity and may require monitoring by a healthcare professional.

Erlotinib should be handled with care, especially by pregnant women or those planning to become pregnant, as it may cause harm to a developing fetus. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication.

Erlotinib may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, smoking can reduce the effectiveness of Erlotinib.